Presenting symptoms in adults with the 22q11 deletion syndrome by Vogels, Annick et al.
1 
 
Citation  Annick Vogels, Sara Schevenels, Richard Cayenberghs, Eddy Weyts, 
Griet Van Buggenhout, Ann Swillen, Hilde Van Esch, Thomy de Ravel, 
Pieter Corveleyn, Koen Devriendt (2014), 
Title  Presenting  symptoms  in  adults  with  the  22q11  deletion 
syndrome 
Eur. J. Med. Genet., Ahead of print. 
Archived version  Author manuscript: the content is identical to the content of the 
published paper, but without the final typesetting by the publisher 
Published version  insert link to the published version of your paper 
http://dx.doi.org/10.1016/j.ejmg.2014.02.008 
Journal homepage  insert link to the journal homepage of your paper 
http://www.journals.elsevier.com/european‐journal‐of‐medical‐
genetics/. 
Author contact  your email annick.vogels@uzleuven.be 
Klik hier als u tekst wilt invoeren. 
IR  url in Lirias https://lirias.kuleuven.be/handle/123456789/445506 
  
 
(article begins on next page) 
   
2 
 
Presenting symptoms in adults with the 22q11 deletion syndrome 
 
Annick Vogelsa*, Sara Schevenelsb, Richard Cayenberghsc, Eddy Weytsc, Griet Van 
Buggenhouta, Ann Swillena, Hilde Van Escha, Thomy de Ravela, Pieter Corveleynb, Koen 
Devriendta 
 
 
aCenter for Human Genetics, KU Leuven,  
bDepartment of Psychiatry, University Hospitals, Leuven 
cSint-Kamillusziekenhuis, Bierbeek, Belgium 
 
 
 
*Corresponding author. Tel.:+32 16 346038  
E-mail address: Annick.Vogels@uzleuven.be 
Herestraat 49, 3000 Leuven, Belgium 
  
3 
 
ABSTRACT  
A definitive molecular diagnosis of 22q11 Deletion Syndrome (22q11DS) even if occurring 
later in life, has important genetic, medical and emotional impact on the patients and their 
families. The aim of this study is to describe presenting symptoms and age at diagnosis in an 
adult 22q11DS population  
A retrospective study was performed on 65 individuals diagnosed with 22q11DS at adult age. 
Data were collected on adults referred to the genetic clinic or actively recruited through 
systematic diagnostic examination in both institutions and a psychiatric unit for intellectually 
disabled. Presenting symptoms were categorized into seven groups: familial occurrence, 
intellectual disability, cardiac anomalies, palatal anomalies, facial dysmorphic features, 
psychiatric problems and ‘other’ (comprising all other features associated with 22q11DS). 
Age at diagnosis was defined as the age at which the 22q11.2 deletion was detected by 
fluorescence in situ hybridization or comparative genomic hybridization. Ascertainment 
subgroups were different in presenting symptoms and age at diagnosis. Adults were referred 
to the genetic clinic mainly because of familial occurrence, cardiac defects and psychiatric 
disorders whereas adults diagnosed in institutions for intellectually disabled presented mainly 
with moderate to severe intellectual disability and psychotic disorders. Adults diagnosed at 
the psychiatric unit for intellectually disabled had a variety of psychiatric disorders but none 
of them had additional physical features.  
This emphasizes the need to stay alert for presenting symptoms such as conotruncal heart 
defects or moderate to severe intellectual disability in combination with a history of 
psychiatric disorders, even in the absence of obvious physical features.  
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Introduction 
The velocardiofacial syndrome also known as the 22q11.2 deletion syndrome (22q11DS), 
is the most common microdeletion syndrome with an estimated prevalence of one in 3000 to 
6000 births [1]. The clinical phenotype is highly variable even within families [2] and more 
than 180 associated anomalies have been described [3]. 
McDonald-McGinn and Sullivan [1] proposed three categories in which to divide the 
possible phenotypic features according to their frequency and their contribution to the 
patient’s quality of life. The most common phenotypic features contributing substantially to 
the medical needs of the patients are defined as major phenotypic features which include 
developmental delay, cardiac anomalies, palatal anomalies and immune deficiency. 
Intermediate phenotypic features are less common but medically important and comprise 
renal anomalies, hypocalcaemia, feeding problems and psychiatric disorders. Minor medical 
features, including the characteristic facial features, contribute to the overall clinical picture 
but are not a major concern to the patient’s medical needs. None of these features occur in all 
patients and none are obligatory [3]. The clinical diagnosis is confirmed by a routine test 
based on FISH, available in most cytogenetic laboratories [2].  
The initial diagnosis of 22q11DS in an individual is dependent on a number of factors, 
including the severity of the phenotypic features, the awareness of the physician and the 
patient’s age [4].  
Most patients are identified at a young age [5]. In infants, congenital cardiac anomalies [6, 
7], cleft palate, feeding difficulties with nasal reflux, congenital thymic hypoplasia and 
neonatal hypocalcemia can lead to the diagnosis of 22q11DS. The majority of the children 
diagnosed after the age of two present with speech-language impairment, developmental 
delay or learning difficulties and recurrent infections [8]. The median age of diagnosis of 
children referred by pediatric cardiologists is 0.5 years, whereas the median age is 8 years for 
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those referred by speech pathologists or cleft palate surgeons and 11.2 years for children 
referred by neurologists/psychiatrists [9]. 
Due to the variability of the phenotypic features and severity, the diagnosis may be missed 
in children [9] and molecular testing is still not performed in many instances where it may 
have been indicated [4]. These undiagnosed patients may not receive adequate social, medical 
and psychiatric care in adolescence and adulthood. A recent survey [10] reported additional 
important psychological benefits for the family of individuals diagnosed at a later age, such as 
having an explanation for a lifelong history of the medical, intellectual and behavioral 
problems, a better understanding of expectations and prognosis and a facilitation of access to 
special programs.  
This study describes the age at diagnosis and the presenting symptoms in 22q11DS adults 
with the aim to identify adult patient groups in whom genetic testing is clinically warranted.  
 
Methodology 
Sample  
“Between January first 1994 and December 31th, 2012, FISH analysis using a probe from 
the commonly deleted 22q11 region was performed in 1241 adults (minimum age 18 years) at 
the Centre for Clinical Genetics of the University Hospitals of Leuven. Out of these sample, 
65(40 females, 25 males) (4.8%) were tested positive. 
The samples were recruited through three methods: FISH analysis for 22q11deletion was 
requested by an external medical professional or a clinical geneticist of the outpatient genetic 
clinic in 842 adults of whom 48(5.7 %) were tested positive. Two hundred eighty six (286) 
adult subjects were tested at the genetic clinics organized in institutions for intellectually 
disabled and13 (4.5 % ) were found to have the deletion. Thirdly, FISH analysis for 22q11 
deletion was performed in113 adults seen as part of a general screening program in a 
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psychiatric inpatient unit for intellectually disabled and out of this group 4 (3.5 %) had a 
22q11 deletion.” 
 
Procedure 
A comprehensive study of the medical records was performed in all 65 patients and 
included data on psychiatric history and cognitive functioning. Only features assessed by a 
medical doctor (physical and psychiatric diagnosis) or a psychologist (cognitive level) were 
included. 
A clinical genetic examination was performed by a clinical geneticist in all referred 
individuals and included data on pedigree, clinical examination, routine chromosome and 
FISH analysis. Earlier missed symptoms or signs were defined as symptoms or signs of 
22q11DS that were not mentioned in the referral letter by the referring physician, but were 
found on the physical examination by the clinical geneticist. Presenting symptoms and signs 
and missed earlier symptoms and signs included diagnostic criteria for 22q11DS.  
All 48 adults (17 males and 31 females) diagnosed at the genetic clinic were referred by a 
general practitioner or a medical specialist. Presenting symptoms were defined as the main 
symptoms or signs that lead to a referral. If there was more than one presenting symptom, the 
main presenting symptom was defined as the symptom that lead to the initial consultation 
with the referring specialist, for example if a cardiologist referred an adult because of a 
cardiac defect and intellectual disability, the cardiac defect was considered to be the main 
presenting symptom.  
A similar procedure was used for adults diagnosed at the institutional genetic clinics but 
FISH analysis for 22q11 deletion was performed only in those residents who, in addition to 
the known intellectual disability, met one or more of the 6 other broad categories of clinical 
screening criteria for 22q11DS. Those include facial anomalies, hypernasal speech, cardiac 
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defect, thymic hypoplasia, hypocalcemia or other birth defects [11]. Psychiatric disorders or 
severe behavior problems were considered as an additional category and a criterion to perform 
FISH analysis. Thirteen individuals (20%) (4 males and 9 females) were diagnosed at the 
institutional genetic clinics. Intellectual disability was considered to be the main presenting 
feature while the other features leading to the decision to perform FISH analysis were 
considered to be a secondary  or tertiary features.  
Four adults (3 males and one female) were diagnosed as part of a general screening 
program for del 22q11 in adults admitted to a psychiatric unit for intellectually disabled. 
Informed consent was obtained from the patients and/or their parents or legal guardian. In this 
group, FISH analysis for detection of 22q11 deletion was performed in all patients regardless 
of the phenotypic features.  
Age at diagnosis was defined as the age at which the result of the FISH analysis was 
available. 
Presenting symptoms were categorized in seven groups based on the classification of 
McDonald-McGinn and Sullivan [1] as described in the introduction: familial occurrence, 
intellectual disability, cardiac anomalies, palatal anomalies, facial dysmorphic features, 
psychiatric problems and ‘other’ (comprising all other features associated with 22q11DS). 
Intellectual capacities were assessed using the Wechsler scales. If no IQ data were available, 
an estimation of daily functioning was made based on data about early psychomotor 
development, learning difficulties at school age and level of professional functioning in 
adulthood. Intellectual disability was classified as borderline IQ (FSIQ 70-85 or a 
developmental age of 12 year), mild intellectual disability (ID) (FSIQ 55-70 or a 
developmental age of 4 to 12 years), moderate ID (FSIQ 40-55 or a developmental age of two 
to 4 years), severe ID (IQ 25-40 or a developmental age of one to two years) or profound ID 
(FSIQ<25 or a developmental age of less than one year) [12].  
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Results 
Age at diagnosis 
The mean age at diagnosis (table 1) in the total sample was 34.03 years (range 18 - 60). 
The average age at diagnosis for individuals diagnosed at the genetic clinic was 30.9 years 
(range 18-54), while the average age at diagnosis for residents of the institutional clinic was 
39.4 years (range 24 - 60). Patients diagnosed at the psychiatric unit for intellectually disabled 
were diagnosed at an average age of 51.5 years (range 45-58). 
Table 1 
Distribution of the study group and age at diagnosis according to the source of ascertainment 
  Number (male/female) Mean age at diagnosis in 
years (range) 
Outpatient genetic clinic 48 (17/31) 30.3 (18-54) 
Institution for 
intellectually disabled 
13 (4/9) 41 (24-60) 
Psychiatric unit for 
patients with dual 
diagnosis 
4 (3/1) 51.75 (45-58) 
 
Presenting symptoms  
Outpatient genetic clinic (n=48)  
Familial occurrence (n=22) 
Twenty two adults (45.8%) were referred to the clinic (table 2) because of a newly 
diagnosed family member. Only seven out of these 22 adults (31.4%) presented with 
additional symptoms : three persons had craniofacial abnormalities including one diagnosed 
with TF, one with a history of learning difficulties and one working in a sheltered workshop. 
The secondary presenting symptom in the fourth patient was a VSD. Two adults were 
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diagnosed with mild intellectual disability and one adult had a history of several psychiatric 
admissions because of paranoid schizophrenia. Mean age at diagnosis was 32.4 years (range 
18-47 years) 
 
Table 2 
Overview of the main presenting symptoms and age at diagnosis in adults referred to the 
genetic clinic 
Main presenting symptom Number of adults diagnosed 
in the genetic clinic (n=48) 
Mean age at diagnosis 
in years (range) 
TOTAL 
 
Familial occurrence 
 Only  
 +ID 
 +FC 
  +CA 
 +PS 
N=48 
 
n=22 (45.8%)  
	 n=15 
 n=2 
 n=3 
 n=1 
	 n=1	
30.9 (18-54) 
 
32.4 (18-47) 
Cardiac anomaly 
 only  
 + ID 
 + FC 
n=15 (31.2%) 
 n=3 
 n=11 
 n=1  
28.6 (19-49) 
Psychiatric disorder 
 only 
 +ID 
 +ID only 
 +ID +FC 
 +ID+CA 
n=7 (14.5%) 
 / 
 n= 7 
 n=3  
 n=3  
 n=1  
29.8 (18-54) 
Intellectual disability  n=2 (4.1%) 33 (18-48) 
Palatal anomaly 
 only 
 + FC 
 + LD 
n=2 (4.1%) 
 / 
 n=1 
 n=1  
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ID: intellectual disability; FC: facial characteristics; CA: cardiac anomalies; LD: learning 
difficulties; PS: psychiatric disorders 
 
These individuals were internally referred by a geneticist after the initial 22q11DS 
diagnosis in the relative (n=18) or they were referred by the gynecologist or the pediatrician 
after the 22q11DS diagnosis in the fetus or newborn (n= 4). 
Twenty one of them had a child with 22q11DS. In one adult the diagnosis was made after 
her sister and then her mother were shown to carry the del22q11.2. 
 
Cardiac anomalies (n=15) 
A cardiac problem was the main presenting symptom in 15 adults (31.2%) and in three 
(3/15) of them it was the only presenting symptom. These three adults presented with 
different cardiac malformations: one had tetralogy of Fallot (TF), another one was diagnosed 
with Ventricle Septal Defect (VSD) with myocard hypertrophy and the third one was referred 
because of TF with pulmonary atresia and major aortopulmonary collateral artery.  
The other 12 adults(12/15) were referred because of a cardiac problem associated with 
secondary symptoms such as intellectual disability (n=11) orcraniofacial abnormalities (n=1). 
Of those presenting with a cardiac malformation and intellectual disability, 7 had also tertiary 
presenting symptoms including craniofacial abnormalities (n=4), short stature and delay of 
puberty (n=1), epilepsy (n=1) and renal agenesis (n=1). The person with craniofacial 
abnormalities as a secondary symptom had learning difficulties as a tertiary symptom. Out of 
these 12 adults, 9 were diagnosed with conotruncal malformations with tetralogy of Fallot 
(TF) in all of them. Five adults presented with TF only while the other four had a complicated 
form of TF: TF with double-outlet right ventricle (DORV) in combination with VSD (n=1), 
TF withDOVR , type agenesis pulmonary valve(n=1) , TF with a right turning aortic arch 
(n=1) and TF with truncus arteriosus (n=1). Three of these 12 adults presented with non-
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conotruncal heart defects: atrium septal defect (n=1), atrioeptal defect in combination with 
VSD and coarctation of the aortic arch (n=1) and AVSD (n=1). 
Mean age at diagnosis was 28.6 years (range 19-49 years). Four adults with a cardiac 
defect died (age at death: 31, 38, 44, 58 years).  
Eleven out of 15 individuals were referred by a (pediatric) cardiologist while two adults 
were referred by a pediatrician. One adult was referred by a general practitioner. Referral data 
were lacking in one adult with cardiac anomalies and intellectual disability. 
 
Psychiatric problems (n=7) 
Seven patients were referred because of a psychiatric disorder or severe behavioural 
problem in combination with intellectual disability. In all of them the combination of 
psychiatric disorder and borderline intelligence or mild intellectual disability were the reason 
for referral and considered as equally important. One intellectually disabled psychiatric 
patient was referred with an additional cardiac anomaly (TF). Three intellectually disabled 
adults had craniofacial characteristics including facial dysmorphy and nasal speech. Two 
adults presented with anxieties including one with a comorbid psychiatric diagnosis of autism 
spectrum disorder. Two adults suffered from psychosis in combination with depression and 
two were diagnosed with schizophrenia. Behavioral problems with verbal and physical 
aggression was reported in one person.  
Mean age at diagnosis was 29.8 years (range 18 to 54 years).  
Five patients including the adult with TF were referred by the psychiatrist. The other two 
adults were referred by the general practitioner.  
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Intellectual disability (n=2) 
Two adults were referred to the genetic clinic with intellectual disability as a primary 
presenting symptom and craniofacial dysmorphism with velopharyngeal insufficiency as a 
secondary symptom. Out of these two , one individual presented with severe and chronic 
thrombocytopenia as a tertiary symptom. Both individuals were referred by general 
practitioners with a special interest in intellectual disability. Mean age at diagnosis was 30.6 
years (18 and 48 years).  
Twelve individuals presented with two or more features whereby intellectual disability was 
considered to be a secondary feature helpful in the decision to refer to the genetic clinic. The 
main presenting symptoms in these adults were: cardiac problems (n=7) and psychiatric 
disorders (n=5).  
 
Palatal anomalies (n=2) 
A palatal anomaly was the only presenting problem in two adults, both referred by the 
otorhinolaryngologist. Mean age at diagnosis was 22 years (19 and 23 years). 
 
Facial features 
None of the adults were referred because of their craniofacial phenotype. Facial features 
were noticed and explicitly mentioned by the referring cardiologist in one subject with cardiac 
anomalies and intellectual disability. 
 
None of the patients were referred because of problems of immune deficiency, 
hypocalcaemia or a history of feeding problems.  
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Missed symptoms  
Hypernasal speech with a history of feeding problems, and facial dysmorphy (micrognathia 
and posterior rotated ears) were the most commonly missed earlier symptoms of 22q11DS 
and were noted in 18 (40%) and 17 (37.7%) individuals respectively. A mild degree of 
intellectual disability had not been reported as a presenting symptom in 13 (28.8 %) adults. 
Cardiac problems (n=2 or 4.4%) and psychiatric disorders (n=2 or 4.4%) were not mentioned 
as presenting symptoms by the referring professional in 4 subjects. Other missed symptoms 
(n=16 or 35.5 %) included scoliosis, a history of recurrent infections, hearing loss and (a 
history of) thrombocytopenia. 
 
Institutions for intellectually disabled (n=13) 
Data on intelligence quotient were available in seven adults and the mean IQ was 61 with a 
range from 46 to 85. Out of the 13 institutionalized adults, one had borderline intelligence 
(FSIQ= 85), two had a mild intellectual disability (FSIQ = 62 and 66), one had a moderate 
intelligence (FSIQ 46). An estimation of cognitive functioning was available in two adults: 
one with moderate and one with severe intellectual disability. Cognitive data were missing in 
the other three adults. 
 
Cardiac anomalies (n=3) 
Three intellectually disabled adults presented with a cardiac anomaly including one with 
TF and two with VSD of whom one also had pulmonary hypertension. The two adults with 
VSD also had a history of psychiatric problems but the exact diagnosis was not known (Table 
3)  
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Psychiatric problems (n=6) 
Six adults had a history of psychiatric disorder in addition to the intellectual disability. 
Five were diagnosed with a psychotic disorder and one adult was described with a 
schizophrenic personality. Comorbid psychiatric diagnoses included autism, depression, 
anxieties and obsessive compulsive disorder.  
 
Facial features (n=3) 
Craniofacial dysmorphy was found in three intellectually disabled adults including one 
who had nasal speech.  
 
Other (n=1) 
One intellectually disabled female presented with thrombocytopenia. She had a history of 
hypothyroidism, anxieties, depression with suicidal ideation and hallucinations. 
 
Table 3 
Overview of the main presenting symptoms in adults seen at the genetic clinic in institutions 
for intellectually disabled. ID: intellectual disability 
Main (ID) and secondary 
presenting symptoms 
Institution for intellectually 
disabled (n=13) 
TOTAL 
 
ID and cardiac anomaly 
 n=13 
 
n=3 (23%) 
ID and psychiatric disorder  n=6 (46%) 
ID and facial features 
 only 
 +palatal anomaly 
n=3 (23%) 
 n=2 (10%) 
 n=1 (10%) 
16 
 
 
Psychiatric inpatient unit for adults with intellectual disability (n=4) 
All four adults were intellectually disabled and were diagnosed with a psychiatric disorder. 
Three adults had a moderate intellectual disability (mean FSIQ: 54, range 49-60) while one 
had a mild intellectual disability (FSIQ 60). One adult was diagnosed with bipolar disorder 
while a second one presented with psychotic disorder paranoid type. Two adults presented 
with severe physical and verbal aggression.  
 
Discussion 
Even if made late during adulthood, the diagnosis of 22q11DS remains of crucial 
importance because of the wide range of medical problems that may occur, resulting in a 
diminished life expectancy, and increased risk of sudden death [13].  
In this study, out of the total 22q11DS population diagnosed after the age of 18 years, 
nearly three fourth were referred to the outpatient genetic clinic and one fourth was actively 
recruited. 
The mean ages of diagnosis in the actively recruited groups in the institutions and in the 
psychiatric hospital (respectively 41.0 en 51.7 years) were higher than the mean age at 
diagnosis in adults referred to the genetic clinic (30.3 years). The earlier age at diagnosis in 
adults seen at the outpatient clinic is mainly the result of familial occurrence i.e. nearly half of 
the adults were diagnosed as young parents following the diagnosis of an affected child. One 
third of the adults referred after an earlier diagnosis in a family member presented with 
additional cardiac, cognitive or psychiatric features. This is contradictory to a previous study 
of adults identified through an affected relative [14], where all 18 adults had only relatively 
mild clinical manifestations and were diagnosed following an earlier diagnosis in an affected 
child. The author pointed out that the presence of minimal clinical signs in 22q11DS parents 
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with an affected child [14], suggest that the adults who survive to reproduce are those without 
major medical complications of the disorder [5].. Our study indicates that also parents with 
moderate to severe clinical manifestations such as psychiatric disorders and cardiac defects 
may remain undiagnosed until they have an affected child.  
 
In this study, one third of the adults referred to the genetic clinic presented with 
conotruncal heart defects, mainly TOF. Nearly all of them were referred by a cardiologist of 
the same hospital reflecting the close collaboration of the genetic clinic and the clinic for 
cardiology. This high prevalence of cardiac anomalies in adults corresponds to the data of a 
previous study that reported cardiac anomalies in one fourth of the adults [15].  
This high rate of cardiac anomalies in adults referred to the genetic clinic is in contrast 
with the absence of cardiac anomalies in the adults diagnosed in the institutions for 
intellectually disabled or diagnosed in the psychiatric unit for intellectually disabled. This low 
prevalence of cardiac defects in the institutionalized adults of our study may be explained by a 
higher neonatal mortality before 1980. All institutionalized and hospitalized adults but one 
were 39 years or older and thus born well before major advances in cardiosurgery. They 
belong to a generation with low survival of congenital heart defect (CHD. Another 
explanation for the low prevalence of CHD in the older institutionalized and hospitalized 
intellectually disabled adults, may be the elevated risk of premature death in adults with 
22q11DS. [13]. 
Although palatal anomalies were considered as a reason for referral in only two 
individuals, it was noticed at the time of the clinical examination by the geneticist in nearly 
half of the adults. This prevalence rate is consistent with the data of a previous study were 
palatal anomalies including submucous cleft and velopharyngeal insufficiency were present in 
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42 % of the adults [15]. These data may indicate that palatal anomalies and/or velopharyngeal 
insufficiency in adults are easily overlooked. [17]. 
 
Psychiatric disorders including psychotic disorders, anxiety disorders and mood disorders 
are well described in adults with 22q11DS, occur in up to 60% [18] and are considered to be a 
prominent problem in adulthood [8]. The psychiatric illness of most concern in the literature 
is psychotic disorder observed in up to one third of the adults [19,20]. Most psychotic 
disorders emerge during the late teens, twenties or thirties and one might expect that a 
relatively high number of patients with mild physical manifestations are diagnosed on the 
occasion of one of these first psychotic episodes. In this study only 14% (7/48) presented with 
psychiatric problems and only 4.% (2/48) presented with a psychotic disorder. This low 
number of adults presenting with psychotic disorders in our total population confirms the 
previous theory of Kook et al. [21] that 22q11DS is rarely suspected among adults presenting 
with a psychotic disorder but without physical abnormalities. On the other hand, we included 
all adults older than 18 and there is still a risk that some of them might develop a psychiatric 
disorder. 
Most individuals (50%) with 22q11DS have borderline intelligence, about 30-40% have 
mild intellectual disability and nearly all of them have a history of learning difficulties at 
school [15, 22]. Although we did not systematically perform a formal assessment of 
intelligence, most adults referred to the genetic clinic had an intellectual disability ranging 
from mild ID to borderline intelligence.  
The majority of the institutionalized adults have a moderate or severe intellectual disability 
compared to the borderline intelligence or mild intellectual disability in those referred to the 
genetic clinic. As there is evidence for a high vulnerability for mental disorder in moderate to 
severely intellectually disabled individuals [23, 24] one may expect institutionalised 22q11DS 
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adults present more often with psychotic disorders. We found that 46% of the institutionalised 
population were diagnosed with 22q11DS because of a history of psychotic disorders. 
Comorbidity was high with autism, depression, anxieties, and obsessive compulsive disorder. 
It is possible that those with a history of psychotic disorders experience a general decline in 
intelligence and adaptive functioning leading to placement in institutions for intellectually 
disabled. Indeed, several studies found that a decrease in verbal skills accompanies the onset 
of psychotic disorders in 22q11DS [25-28]. Another explanation may be that clinical 
geneticists working at these institutional clinics are familiar with the psychiatric phenotype of 
this syndrome and have an enhanced index of suspicion which may contribute to a higher 
detection rate.  
Moderate or severe levels of intellectual disability are known to be rare in 22q11DS [15, 
30] and the diagnosis is rarely considered in this population. It is therefore possible that 
without the active recruitment policy of the genetic clinic, the adults residing in institutions 
for intellectually disabled and in the psychiatric unit for intellectually disabled would never 
have been diagnosed. 
Although the clinical geneticist noticed typical craniofacial features in nearly half of the 
adults only one physician mentioned these features in the referral letter. This is consistent 
with a previous report [17] stating that the facial features are not as distinctive or abnormal as 
in some other genetic syndromes and thus may be easily missed by non-geneticists. Clinical 
geneticists are used to evaluate facial features and one might thus expect a high detection rate 
in the genetic clinics for institutionalized intellectually disabled adults but only a few patients 
showed the typical craniofacial phenotype. The average age of the population seen at the 
institutions is high and it may be possible that the typical facial features become less evident 
with age. Facial features may also be less pronounced in adults with a more severe form of 
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intellectual disability and/or a long history of psychotic disorders and use of psycho-
pharmaceuticals. 
We thus found that adults with a moderate to severely intellectually disability are 
diagnosed at an older age, rarely have less typical craniofacial features, have a high risk for 
psychiatric disorders and a lower risk for cardiac malformations. These findings are 
confirmed by the results of a general screening for del22q11 in a population of adults with 
moderate to severe intellectual disability and severe psychiatric disorders. Out of the 113 
adults tested, four were tested positive for 22q11DS and none of them showed, apart from the 
intellectual disability any of the clinical screening criteria for 22q11DS. All four of them were 
older than 45 at the time of diagnosis and the chance that they would have been diagnosed 
outside this screening program is low. 
These results raise the possibility that the deletion in moderate to severely intellectually 
disabled adults with psychiatric disorders and without any physical symptoms is more 
common than previously reported and easily missed. It emphasizes the need to broaden the 
index of suspicion for developmental psychiatrists.  
 
Conclusion 
Familial occurrence is the most frequent indication for adults with 22q11DS to be referred 
to the genetic clinic followed by cardiac anomalies with or without other features. A moderate 
to severe developmental delay with a psychiatric disorder were the main presenting symptoms 
in adults ascertained through intellectually disabled resources. This emphasis the need to stay 
alert for presenting symptoms such as moderate to severe intellectual disability in 
combination with a history of psychiatric disorders, particularly in the absence of obvious 
physical features.  
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In summary, an increased index of suspicion in moderately to severely retarded adults with 
severe psychiatric disorders as well as in adults with a borderline intelligence and cardiac 
defects and/or a history of feeding problems and hypernasal speech could lead to more 
diagnoses of 22q11DS and benefit the patient and his family.  
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